Drug intelligence / Profile preview

ricinoleic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Ricinoleic acid is a hydroxylated long-chain fatty acid primarily found in castor oil. It is the main active component released from castor oil by intestinal lipases and is responsible for its pharmacological effects. Ricinoleic acid acts as an agonist at prostaglandin E2 receptor EP3 subtype and EP4 subtype on smooth muscle cells of the intestine and uterus. Activation of these receptors leads to increased intestinal peristalsis (laxative effect) and uterine contractions[1][6][8]. Additionally, ricinoleic acid has demonstrated anti-inflammatory and analgesic properties when applied topically or systemically[3][4]. Its mechanism involves selective activation of EP3 and EP4 prostanoid receptors; it does not activate other prostanoid receptors such as IP, DP1/DP2, FP or TP[6][8].

Other names
(cis,R)-12-hydroxyoctadec-9-enoic acid(Z,R)-12-hydroxyoctadec-9-enoic acid12-Hydroxy-9-octadecenoic acid12-Hydroxy-cis-9-octadecenoic acid12-hydroxyoleic acidricinolic acidRicinolsäure
02

Targets

PTGER3 (Prostaglandin E2 receptor EP3 subtype)PTGER4 (Prostaglandin E2 receptor EP4 subtype)

Beyond the preview

Go deeper on ricinoleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ricinoleic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call